Targeted Tumor Therapy with Radiolabeled DNA Intercalator: A Possibility? Preclinical Investigations with <sup>177</sup>Lu-Acridine

<div>Variation of % radiolabeling yield of <sup>177</sup>Lu-acridine complex with ligand concentration.</div>

BioMed Research International

Figure 3: Targeted Tumor Therapy with Radiolabeled DNA Intercalator: A Possibility? Preclinical Investigations with <sup>177</sup>Lu-Acridine 